Risk factors and prognosis of anterior commissure versus posterior commissure T1-T2 glottic cancer
- PMID: 12656413
- DOI: 10.1177/000348940311200306
Risk factors and prognosis of anterior commissure versus posterior commissure T1-T2 glottic cancer
Abstract
For better understanding of the causation and behavior of T1-T2 commissural glottic laryngeal tumors, we retrospectively analyzed risk factors and outcome related to T class and type of therapy for tumors involving the anterior (184 cases) or the posterior (60 cases) commissure. The patients' smoking habits and alcohol consumption were similar, regardless of involved subsite. The disease-free interval was longer after surgery than after radiotherapy. The survival rates after recovery upon relapse were similar among subsites, T classes, and types of therapy. In anterior commissure tumors, the larynx remained preserved more frequently after partial laryngeal resection than after radiotherapy, and was more frequently preserved the lower the T class. In posterior commissure tumors, larynx preservation was less frequent and apparently independent of type of therapy or T class. In conclusion, smoking and alcohol consumption play similar pathogenetic roles in either subsite; partial laryngeal resection gave a higher rate of laryngeal preservation than did radiotherapy; and anatomic peculiarities of the subsites influence tumor behavior.
Similar articles
-
T1 glottic carcinoma involving the posterior commissure.Laryngoscope. 2009 Jun;119(6):1116-9. doi: 10.1002/lary.20138. Laryngoscope. 2009. PMID: 19308987
-
Importance of anterior commissure in recurrence of early glottic cancer after laser endoscopic resection.Arch Otolaryngol Head Neck Surg. 2007 Sep;133(9):882-7. doi: 10.1001/archotol.133.9.882. Arch Otolaryngol Head Neck Surg. 2007. PMID: 17875854
-
Epidermal growth factor receptor and p53 expression in T1-T2 glottic cancer involving the anterior or posterior commissure.Acta Otolaryngol. 2004 Jan;124(1):102-6. doi: 10.1080/00016480310014886. Acta Otolaryngol. 2004. PMID: 14977086
-
The prognostic value of anterior commissure involvement in T1 glottic cancer: A systematic review and meta-analysis.Laryngoscope. 2020 Aug;130(8):1932-1940. doi: 10.1002/lary.28395. Epub 2019 Nov 13. Laryngoscope. 2020. PMID: 31721216
-
Management of T1-T2 glottic carcinomas.Cancer. 2004 May 1;100(9):1786-92. doi: 10.1002/cncr.20181. Cancer. 2004. PMID: 15112257 Review.
Cited by
-
Oncological Outcomes Following Transoral CO2 Laser Microsurgery for T1 Glottic Cancer.Indian J Otolaryngol Head Neck Surg. 2019 Oct;71(Suppl 1):542-547. doi: 10.1007/s12070-018-1394-4. Epub 2018 May 14. Indian J Otolaryngol Head Neck Surg. 2019. PMID: 31742018 Free PMC article.
-
Hypofractionated radiotherapy for early stage glottic cancer: efficacy of 3.5 Gy per fraction.Radiat Oncol J. 2022 Jun;40(2):120-126. doi: 10.3857/roj.2021.01025. Epub 2022 May 17. Radiat Oncol J. 2022. PMID: 35796115 Free PMC article.
-
Prognostic factors in the treatment of squamous cell carcinoma of the larynx: partial surgery x radical surgery.Braz J Otorhinolaryngol. 2007 Nov-Dec;73(6):816-825. doi: 10.1016/S1808-8694(15)31178-2. Braz J Otorhinolaryngol. 2007. PMID: 18278228 Free PMC article.
-
Transoral laser microsurgery in early glottic cancer involving the anterior commissure.Eur Arch Otorhinolaryngol. 2019 Mar;276(3):837-845. doi: 10.1007/s00405-018-5261-4. Epub 2019 Jan 2. Eur Arch Otorhinolaryngol. 2019. PMID: 30604057
-
Primary treatment of the anterior vocal commissure squamous carcinoma.Eur Arch Otorhinolaryngol. 2006 Oct;263(10):879-88. doi: 10.1007/s00405-006-0138-3. Epub 2006 Aug 15. Eur Arch Otorhinolaryngol. 2006. PMID: 16909217 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources